Cargando…

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis

Detalles Bibliográficos
Autores principales:	Heudobler, Daniel, Reichle, Albrecht, Ghibelli, Lina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528999/ https://www.ncbi.nlm.nih.gov/pubmed/34690792 http://dx.doi.org/10.3389/fphar.2021.779021

Ejemplares similares

Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction
por: Heudobler, Daniel, et al.
Publicado: (2019)

Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity
por: Heudobler, Daniel, et al.
Publicado: (2022)

A Computational Model of Tumor Growth and Anakoinosis
por: Pantziarka, Pan, et al.
Publicado: (2019)

Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis
por: Heudobler, Daniel, et al.
Publicado: (2018)

Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)
por: Reichle, Albrecht, et al.
Publicado: (2020)

Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia
por: Hart, Christina, et al.
Publicado: (2015)

Metronomics: Intrinsic Anakoinosis Modulator?
por: Nicolas, André, et al.
Publicado: (2018)

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML
por: Heudobler, Daniel, et al.
Publicado: (2018)

Drug Repurposing by Tumor Tissue Editing
por: Lüke, Florian, et al.
Publicado: (2022)

Lowering Etoposide Doses Shifts Cell Demise From Caspase-Dependent to Differentiation and Caspase-3-Independent Apoptosis via DNA Damage Response, Inducing AML Culture Extinction
por: Bruni, Emanuele, et al.
Publicado: (2018)

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
por: Heudobler, Daniel, et al.
Publicado: (2018)

Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis
por: Klobuch, Sebastian, et al.
Publicado: (2018)

Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy
por: Lüke, Florian, et al.
Publicado: (2021)

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease
por: Lüke, Florian, et al.
Publicado: (2021)

Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023)

Editorial: Adipose Tissue in the Cardiovascular Homeostasis and Disease
por: Butcher, Joshua T., et al.
Publicado: (2021)

Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment
por: Kleszcz, Robert
Publicado: (2023)

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
por: Griffin, Matthew D., et al.
Publicado: (2020)

Glutathione depletion in survival and apoptotic pathways
por: De Nicola, Milena, et al.
Publicado: (2014)

Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy
por: Kattner, Anna-Sophia, et al.
Publicado: (2020)

A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)
por: Heudobler, Daniel, et al.
Publicado: (2021)

Editorial: Innovation in ocular pharmacology
por: Gozzo, Lucia, et al.
Publicado: (2023)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer
por: Corsi, Francesca, et al.
Publicado: (2022)

Targeting Tumor Perfusion and Oxygenation to Improve the Outcome of Anticancer Therapy
por: Jordan, Bénédicte F., et al.
Publicado: (2012)

Editorial: Molecular and multi-omic approaches in understanding cancer biology and anticancer therapies: current perspectives and new challenges
por: Abdel-Wahab, Basel A., et al.
Publicado: (2023)

Editorial: Mechanisms Underlying Diabetes-Associated Damage in Target Tissues
por: Suarez-Alvarez, Beatriz, et al.
Publicado: (2022)

Editorial: C. elegans as an emerging model of pharmacological innovation
por: Huang, Zebo, et al.
Publicado: (2022)

Carnitine Palmitoyltransferase System: A New Target for Anti-Inflammatory and Anticancer Therapy?
por: Wang, Muyun, et al.
Publicado: (2021)

Editorial: The roles of immune cell homeostasis in cancer research and therapeutic response
por: Zhang, Kui, et al.
Publicado: (2023)

Editorial: Novel small molecules in targeted cancer therapy
por: Li, Rong, et al.
Publicado: (2023)

Editorial: Discovering novel anticancer molecules and revealing the pharmacological mechanism of gastrointestinal carcinoma
por: Xia, Yong, et al.
Publicado: (2022)

Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
por: Jaafari, Abdeslam, et al.
Publicado: (2022)

Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition
por: Pelliccia, Andrea, et al.
Publicado: (2023)

Systems Biology: A Therapeutic Target for Tumor Therapy
por: Reichle, Albrecht, et al.
Publicado: (2008)

Editorial: The Potential Effect and Mechanism of Chinese Traditional Medicine on Vascular Homeostasis and Remodeling
por: Wang, Yuliang, et al.
Publicado: (2020)

Editorial: The Potential Effect and Mechanism of Traditional Medicine on Vascular Homeostasis and Remodeling: An Update
por: Zhang, Yuefan, et al.
Publicado: (2022)

Editorial: Innovative pharmacometric approaches to inform drug development and clinical use
por: Garcia-Cremades, Maria, et al.
Publicado: (2023)

Editorial: Cardiorenal dysregulation in endocrine disorders: innovative mechanisms and therapeutic interventions
por: Shawky, Noha M., et al.
Publicado: (2023)

Urokinase receptor and resistance to targeted anticancer agents
por: Gonias, Steven L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ue3tk5hnl2q1ocmfue82slb71d